When did Xtant Medical Holdings report Q4 2024 earnings?

Xtant Medical Holdings (XTNT) reported Q4 2024 earnings on March 6, 2025 after market close.

What were Xtant Medical Holdings's Q4 2024 revenue and EPS?

Xtant Medical Holdings reported revenue of $31.5M and eps of $-0.02 for Q4 2024.

Did Xtant Medical Holdings beat estimates in Q4 2024?

Revenue missed the consensus estimate of $31.8M by $282.0K. EPS missed the consensus estimate of $-0.01 by $0.01.

Where can I find Xtant Medical Holdings's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001493152-25-009391) directly on SEC EDGAR. The filing index links above go to sec.gov.

Xtant Medical Holdings XTNT Q4 2024 Annual earnings

Reported March 6, 2025 · After market close

Revenue$31.5MMiss by $282.0K

EPS-$0.02Miss by $0.01

Revenue estimate$31.8M

EPS estimate-$0.01

Next report

Aug 12, 2026 (In 2 weeks)

Revenue estimate$24.9M

EPS estimate-$0.02

Financials

Q4 2024

Income statement

See full

Revenue$31.5M+12.1%

Gross profit$16.0M-6.5%

Operating income-$1.9M+50.6%

Net income-$3.2M—

EPS (diluted)-$0.02—

Balance sheet

See full

Cash & equivalents$6.2M+5.0%

Total debt$23.0M+21.6%

Total equity$43.0M-16.3%

Total assets$93.8M+1.3%

Cash flow

See full

Operating cash flow-+100%

CapEx$672.0K+85.1%

Free cash flow-$7.0K+99.5%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$61.58M-58.1%

Enterprise value$78.38M-51.0%

P/S0.5×-1.1×

Profitability

See full

Gross margin58.2%-2.6pp

Operating margin-10.3%-0.7pp

Net margin-14%—

FCF margin-13.7%+2.2pp

Returns & leverage

See full

Return on equity-34.9%—

Debt / equity0.5×+0.2×

Current ratio2.3×-0.5×

Segments

By product

See full

Orthobiologics$18.3M+21.4%

Spinal Implant$11.7M-10.1%

Versus estimates

Revenue

Q1 2026$20.9MBeat by $719.7K Q4 2025$32.4MBeat by $1.6M Q3 2025$33.3MBeat by $2.5M Q2 2025$35.4MBeat by $4.2M Q1 2025$32.9MBeat by $1.7M

Q4 2024$31.5MMiss by $282.0K

Diluted EPS

Q1 2026-$0.02Miss by $0.01 Q4 2025$0.00Beat by $0.01 Q3 2025$0.01Beat by $0.02 Q2 2025$0.02Beat by $0.03 Q1 2025$0.00Beat by $0.01

Q4 2024-$0.02Miss by $0.01

Ask the moment Xtant Medical Holdings reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Xtant Medical Holdings report Q4 2024 earnings?: Xtant Medical Holdings (XTNT) reported Q4 2024 earnings on March 6, 2025 after market close.
What were Xtant Medical Holdings's Q4 2024 revenue and EPS?: Xtant Medical Holdings reported revenue of $31.5M and eps of $-0.02 for Q4 2024.
Did Xtant Medical Holdings beat estimates in Q4 2024?: Revenue missed the consensus estimate of $31.8M by $282.0K. EPS missed the consensus estimate of $-0.01 by $0.01.
Where can I find Xtant Medical Holdings's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001493152-25-009391) directly on SEC EDGAR. The filing index links above go to sec.gov.